Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43AI039310-01
Application #
2076397
Study Section
Special Emphasis Panel (ZRG7-SSS-Y (01))
Project Start
1996-09-30
Project End
1997-03-31
Budget Start
1996-09-30
Budget End
1997-03-31
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost

  Institution

Name
Dorlin Pharmaceuticals, Inc.
Department
Type
DUNS #
City
Baltimore
State
MD
Country
United States
Zip Code
21227

  Publications

Laakso, Jodi A; Raulli, Robert; McElhaney-Feser, Gail E et al. (2003) CT2108A and B: New fatty acid synthase inhibitors as antifungal agents. J Nat Prod 66:1041-6
Zhao, X J; McElhaney-Feser, G E; Sheridan, M J et al. (1997) Avirulence of Candida albicans FAS2 mutants in a mouse model of systemic candidiasis. Infect Immun 65:829-32